KAPPA BIOSCIENCE
Kappa Bioscience is the pioneer in the development and production of the only synthetic and biologically active all-trans menaquinone-7 (vitamin K2 MK-7), marketed under the K2VITAL brand name. Kappaโs innovation of MK-7 synthesis marks the commercial milestone where this fat-soluble vitamin can begin to attain widespread consumer adoption. Effective synthesis production drives scalability, price reduction, and a secure supply chain - with unmatched ingredient purity and documentation. Combine... d with other Kappa innovations such as the patented DELTA microencapsulation process, which provides K2 stability in mineral formulations, K2VITAL offers brands and manufacturers a path to broader market segments. Kappa Ingredients GmbH, a wholly-owned division of Kappa Bioscience, manages global sales of the K2VITAL and other product lines directly and through a network of global distributors. Kappa Ingredients GmbH, a wholly-owned division of Kappa Bioscience, manages global sales of the K2VITAL and other product lines - Ingredients and services related to Bones, Joints, and Cardiovascular Health - directly and through a network of global distributors. The main products are Vitamin K2 - K2VITAL, Calcified Atlantic Seaweed, and The Bone Health Triangle.
KAPPA BIOSCIENCE
Industry:
Biotechnology Life Science Pharmaceutical Wellness
Founded:
2006-12-01
Address:
Oslo, Oslo, Norway
Country:
Norway
Website Url:
http://www.kappabio.com
Total Employee:
11+
Status:
Active
Contact:
+49 40 6094087 0
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Euro IPv6 Apple Mobile Web App Capable Pound Sterling Japanese Yen
Similar Organizations
![]()
Signum Biosciences
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Current Advisors List
Current Employees Featured

Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-01-24 | ppm.Ingredients | ppm.Ingredients acquired by Kappa Bioscience | N/A |
Investors List
![]()
SPRINGfondet
SPRINGfondet investment in Venture Round - Kappa Bioscience
![]()
Kistefos Venture Capital
Kistefos Venture Capital investment in Venture Round - Kappa Bioscience
Official Site Inspections
http://www.kappabio.com Semrush global rank: 4.48 M Semrush visits lastest month: 2.42 K
Unable to get host informations!!!
